Equities
Health CareHealth Care Providers
  • Price (USD)298.11
  • Today's Change2.40 / 0.81%
  • Shares traded1.45m
  • 1 Year change-42.18%
  • Beta0.5297
Data delayed at least 15 minutes, as of Nov 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.

  • Revenue in USD (TTM)115.01bn
  • Net income in USD1.36bn
  • Incorporated1964
  • Employees67.60k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.humana.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ensign Group Inc4.11bn239.98m8.39bn35.30k35.434.8026.092.044.134.1370.8630.500.9433--8.01116,391.305.526.456.637.8821.1922.325.856.48----0.07736.5623.2716.28-6.8028.624.405.02
Chemed Corp2.38bn301.73m8.55bn15.09k28.866.9023.473.6019.7819.78155.8282.781.43136.4913.04157,566.5018.1119.5321.7924.6435.6634.6012.6912.601.81--0.008.156.064.909.175.801.466.10
Encompass Health Corp5.22bn431.20m10.19bn22.36k23.935.2011.921.954.234.1151.1019.450.8396--9.38233,270.709.076.3711.877.9495.4995.5810.809.16--6.140.48630.7810.412.3441.314.4916.60-10.42
Universal Health Services, Inc.15.42bn1.03bn13.07bn73.35k13.171.988.020.847815.0315.03225.85100.141.09--6.93210,194.407.416.448.687.63----6.786.551.287.700.41056.066.595.806.32-1.471.1714.87
Davita Inc12.67bn827.68m13.57bn70.00k17.8435.367.231.079.289.28141.504.680.735771.345.90180,951.606.585.628.887.4532.8030.708.948.331.334.770.8115--4.571.2626.442.33-10.47--
Tenet Healthcare Corp20.97bn3.13bn13.66bn78.14k4.593.562.850.651331.2631.26209.8140.320.73649.497.15268,376.3013.863.6120.235.0982.6182.9718.834.951.525.370.61450.007.172.3349.0241.424.01--
Molina Healthcare Inc39.20bn1.14bn16.63bn18.00k14.763.4712.550.424319.7019.70674.9783.682.56--13.712,177,722.007.477.6216.5816.8016.1215.992.923.04--14.830.34650.006.5612.5237.759.0622.87--
Quest Diagnostics Inc9.54bn838.00m18.26bn40.00k21.962.6913.681.917.457.4584.7960.790.64534.777.18238,475.005.879.286.7710.8132.9436.649.1012.971.178.870.474625.07-6.384.20-9.773.401.277.43
Labcorp Holdings Inc12.71bn435.50m20.05bn67.00k46.452.4618.981.585.165.16150.4097.610.716219.415.93189,743.302.466.273.007.3727.9232.333.449.511.305.590.455--2.511.42-62.16-16.403.62--
Natera Inc1.53bn-214.69m20.69bn3.28k--23.63--13.50-1.77-1.7712.597.081.0114.295.45466,774.80-14.14-36.17-17.55-46.6057.6645.88-14.01-56.154.23--0.2947--31.9933.2620.63--58.81--
Centene Corp161.73bn3.07bn30.48bn67.70k10.471.137.100.18855.775.77303.7253.531.94--9.572,388,863.003.662.586.393.9910.3711.591.891.37--4.060.39110.006.5420.70124.7924.593.43--
Humana Inc115.01bn1.36bn35.90bn67.60k26.392.0414.930.312111.2911.29948.23145.882.17----1,701,331.002.727.57--------1.253.35--5.380.424912.5414.5413.33-11.307.6510.4113.25
Data as of Nov 23 2024. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD

Institutional shareholders

37.26%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202410.54m8.76%
BlackRock Fund Advisorsas of 30 Sep 20246.67m5.54%
SSgA Funds Management, Inc.as of 30 Sep 20245.36m4.45%
Dodge & Coxas of 30 Sep 20244.93m4.10%
Wellington Management Co. LLPas of 30 Sep 20244.40m3.66%
Eagle Capital Management LLCas of 30 Sep 20243.25m2.70%
Geode Capital Management LLCas of 30 Sep 20242.82m2.34%
Pzena Investment Management LLCas of 30 Sep 20242.51m2.08%
Davis Selected Advisers LPas of 30 Sep 20242.31m1.92%
T. Rowe Price Associates, Inc. (IM)as of 30 Sep 20242.07m1.72%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.